Sundrug Co.,Ltd. (SDGCF)
USD 28.18
(0.0%)
USD 28.18
(0.0%)
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2024 | 189.32 Billion JPY | 14527.92% |
| 2023 | 1.29 Billion JPY | 0.66% |
| 2022 | 1.28 Billion JPY | -10.39% |
| 2021 | 1.43 Billion JPY | 0.18% |
| 2020 | 1.43 Billion JPY | 7.71% |
| 2019 | 1.32 Billion JPY | 0.32% |
| 2018 | 1.32 Billion JPY | 12.96% |
| 2017 | 1.17 Billion JPY | 6.25% |
| 2016 | 1.1 Billion JPY | -98.98% |
| 2015 | 108.23 Billion JPY | 2.26% |
| 2014 | 105.84 Billion JPY | 9.65% |
| 2013 | 96.53 Billion JPY | 7.39% |
| 2012 | 89.88 Billion JPY | 9.89% |
| 2011 | 81.79 Billion JPY | 24.31% |
| 2010 | 65.8 Billion JPY | 20.11% |
| 2009 | 54.78 Billion JPY | 8.85% |
| 2008 | 50.33 Billion JPY | 10.52% |
| 2007 | 45.54 Billion JPY | 14.54% |
| 2006 | 39.76 Billion JPY | 17.26% |
| 2005 | 33.9 Billion JPY | 0.0% |
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2024 Q3 | 351.57 Million JPY | 10.07% |
| 2024 Q1 | 313.28 Million JPY | -6.0% |
| 2024 Q2 | 319.4 Million JPY | 1.96% |
| 2024 Q4 | 46.76 Billion JPY | 13200.84% |
| 2024 FY | 189.32 Billion JPY | 14527.92% |
| 2023 FY | 1.29 Billion JPY | 0.66% |
| 2023 Q3 | 346.67 Million JPY | 18.98% |
| 2023 Q2 | 291.37 Million JPY | -1.11% |
| 2023 Q1 | 294.64 Million JPY | -5.31% |
| 2023 Q4 | 333.28 Million JPY | -3.86% |
| 2022 Q2 | 351.27 Million JPY | -0.69% |
| 2022 Q1 | 353.72 Million JPY | 2.21% |
| 2022 Q3 | 349.77 Million JPY | -0.43% |
| 2022 Q4 | 311.15 Million JPY | -11.04% |
| 2022 FY | 1.28 Billion JPY | -10.39% |
| 2021 Q2 | 39.69 Billion JPY | 1.63% |
| 2021 FY | 1.43 Billion JPY | 0.18% |
| 2021 Q1 | 39.05 Billion JPY | 1.52% |
| 2021 Q4 | 346.09 Million JPY | -99.17% |
| 2021 Q3 | 41.55 Billion JPY | 4.7% |
| 2020 Q2 | 40.46 Billion JPY | 5.5% |
| 2020 FY | 1.43 Billion JPY | 7.71% |
| 2020 Q1 | 38.35 Billion JPY | 5.23% |
| 2020 Q3 | 37.33 Billion JPY | -7.72% |
| 2020 Q4 | 38.47 Billion JPY | 3.04% |
| 2019 FY | 1.32 Billion JPY | 0.32% |
| 2019 Q1 | 36.06 Billion JPY | 1.83% |
| 2019 Q2 | 36.56 Billion JPY | 1.39% |
| 2019 Q3 | 38.1 Billion JPY | 4.22% |
| 2019 Q4 | 36.44 Billion JPY | -4.36% |
| 2018 Q4 | 35.41 Billion JPY | -3.62% |
| 2018 Q3 | 36.74 Billion JPY | 5.63% |
| 2018 Q2 | 34.78 Billion JPY | 2.28% |
| 2018 Q1 | 34.01 Billion JPY | 3.28% |
| 2018 FY | 1.32 Billion JPY | 12.96% |
| 2017 FY | 1.17 Billion JPY | 6.25% |
| 2017 Q3 | 34.19 Billion JPY | 6.6% |
| 2017 Q2 | 32.07 Billion JPY | 1.65% |
| 2017 Q1 | 31.55 Billion JPY | 0.51% |
| 2017 Q4 | 32.92 Billion JPY | -3.69% |
| 2016 FY | 1.1 Billion JPY | -98.98% |
| 2016 Q2 | 31.08 Billion JPY | 5.69% |
| 2016 Q1 | 29.41 Billion JPY | 3.68% |
| 2016 Q3 | 32.22 Billion JPY | 3.66% |
| 2016 Q4 | 31.39 Billion JPY | -2.58% |
| 2015 FY | 108.23 Billion JPY | 2.26% |
| 2015 Q1 | 24.39 Billion JPY | -11.64% |
| 2015 Q4 | 28.36 Billion JPY | -3.5% |
| 2015 Q3 | 29.39 Billion JPY | 12.71% |
| 2015 Q2 | 26.08 Billion JPY | 6.92% |
| 2014 Q4 | 27.6 Billion JPY | 4.0% |
| 2014 FY | 105.84 Billion JPY | 9.65% |
| 2014 Q1 | 25.24 Billion JPY | 3.28% |
| 2014 Q2 | 26.45 Billion JPY | 4.76% |
| 2014 Q3 | 26.54 Billion JPY | 0.35% |
| 2013 Q4 | 24.44 Billion JPY | -1.6% |
| 2013 FY | 96.53 Billion JPY | 7.39% |
| 2013 Q1 | 22.88 Billion JPY | -0.8% |
| 2013 Q2 | 24.35 Billion JPY | 6.42% |
| 2013 Q3 | 24.84 Billion JPY | 2.0% |
| 2012 Q3 | 23.22 Billion JPY | 3.8% |
| 2012 Q2 | 22.37 Billion JPY | 5.41% |
| 2012 Q1 | 21.22 Billion JPY | 1.79% |
| 2012 FY | 89.88 Billion JPY | 9.89% |
| 2012 Q4 | 23.07 Billion JPY | -0.65% |
| 2011 Q1 | 19.23 Billion JPY | -3.65% |
| 2011 Q3 | 21.04 Billion JPY | 1.85% |
| 2011 Q2 | 20.66 Billion JPY | 7.4% |
| 2011 FY | 81.79 Billion JPY | 24.31% |
| 2011 Q4 | 20.85 Billion JPY | -0.92% |
| 2010 Q3 | 15.88 Billion JPY | 2.04% |
| 2010 Q1 | 14.37 Billion JPY | 0.0% |
| 2010 FY | 65.8 Billion JPY | 20.11% |
| 2010 Q4 | 19.96 Billion JPY | 25.69% |
| 2010 Q2 | 15.56 Billion JPY | 8.28% |
| 2009 FY | 54.78 Billion JPY | 8.85% |
| 2008 FY | 50.33 Billion JPY | 10.52% |
| 2007 FY | 45.54 Billion JPY | 14.54% |
| 2006 FY | 39.76 Billion JPY | 17.26% |
| 2005 FY | 33.9 Billion JPY | 0.0% |
| Name | Gross Profit | Gross Profit Difference |
|---|---|---|
| Alternative Energy Partners, Inc. | - USD | -Infinity% |
| Allstar Health Brands, Inc. | - USD | -Infinity% |
| Beijing Tong Ren Tang Chinese Medicine Company Limited | 134.07 Million USD | -141100.842% |
| Café Serendipity Holdings, Inc. | 1196.00 USD | -15829431338.127% |
| Decision Diagnostics Corp. | - USD | -Infinity% |
| Health Advance Inc. | - USD | -Infinity% |
| HealthWarehouse.com, Inc. | 12.17 Million USD | -1555028.066% |
| LIGAND PHARMACEUTICAL INC | 88.02 Million USD | -214972.819% |
| MedGen, Inc. | 1.05 USD | -18030476190376.19% |
| Omni Health, Inc. | 1.55 Million USD | -12194087.214% |
| Oxford Investments Holdings Inc. | 31.45 Thousand USD | -601818197.412% |
| Pineapple, Inc. | -1.02 Million USD | 18475895.654% |
| ScripsAmerica, Inc. | 27.59 Million USD | -685914.384% |